Phoenix Oncology Institute Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
as on 17-12-2024
- Paid Up Capital ₹ 0.15 M
as on 17-12-2024
- Company Age 1 Year 2 Months
- Last Filing with ROC 31 Mar 2024
About Phoenix Oncology Institute
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.15 M, as per Ministry of Corporate Affairs (MCA) records.
Kaushik Hari, Raveendranath Pinnamaneni, and Kunisetty Vamsi serve as directors at the Company.
- CIN/LLPIN
U86100AP2023PTC112667
- Company No.
112667
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
16 Oct 2023
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Vijayawada
Company Details
- Location
Guntur, Andhra Pradesh, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Phoenix Oncology Institute?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Kaushik Hari  | Director | 16-Oct-2023 | Current |
| Raveendranath Pinnamaneni | Director | 16-Oct-2023 | Current |
| Kunisetty Vamsi | Director | 16-Oct-2023 | Current |
Financial Performance of Phoenix Oncology Institute.
Enhance accessibility to Phoenix Oncology Institute's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Phoenix Oncology Institute?
Unlock access to Phoenix Oncology Institute's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Precisto Industries Private LimitedActive 5 years 10 monthsKaushik Hari, Raveendranath Pinnamaneni and 1 more are mutual person
- Rkglobal Industriesprivate LimitedActive 5 years 9 months
Kaushik Hari and Raveendranath Pinnamaneni are mutual person
- Medisys Innovations Private LimitedActive 3 years 6 months
Kaushik Hari, Raveendranath Pinnamaneni and 1 more are mutual person
- Kakinada Institute Of Oncology Private LimitedActive 3 years 6 months
Kaushik Hari is a mutual person
- Sushruthahealth Care Services Private LimitedActive 5 years 4 months
Kaushik Hari is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Phoenix Oncology Institute?
Unlock and access historical data on people associated with Phoenix Oncology Institute, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Phoenix Oncology Institute, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Phoenix Oncology Institute's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.